Education
About Us
Working with TipRanks
Follow Us
Semler Scientific (SMLR)
NASDAQ:SMLR
SMLR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$20.88 - $81.56
Previous CloseN/A
Volume122.03K
Average Volume (3M)401.03K
Market Cap
$354.30M
Enterprise Value$447.62M
Total Cash (Recent Filing)$8.82M
Total Debt (Recent Filing)$70.00K
Price to Earnings (P/E)7.5
Beta2.12
Next Earnings
May 13, 2025EPS Estimate
0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.91
Shares Outstanding9,596,486
10 Day Avg. Volume347,857
30 Day Avg. Volume401,027
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)N/A
Price to Sales (P/S)6.69
Price to Cash Flow (P/CF)12.70
P/FCF Ratio12.70
Enterprise Value/Market Cap1.26
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.69
Enterprise Value/Ebitda21.38
Forecast
1Y Price Target
$71.00Price Target Upside92.62% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Semler Scientific News
---
Bulls Say, Bears Say
Bulls Say
Cash FlowThe business is generating significant positive free cash flow now, and this is expected to continue.
Regulatory ApprovalSemler is seeking to obtain a new 510(k) clearance from the FDA that would allow the Company to market a heart dysfunction product.
Treasury StrategyThe Company has added Bitcoin to its Treasury strategy, and it is clear management and the Board view Bitcoin as central to the future of Semler.
Bears Say
Bitcoin VolatilityThe inherent volatility of Bitcoin is viewed as a risk for investors.
Cryptocurrency HoldingsThe Company had an unrealized gain of roughly $29M from BTC in the quarter and ended Q4 with roughly $9M of cash.
Regulatory ChangesPreliminary 4Q results again reflected some of the fallout from last year’s announcement of CMS’ decision to phase out risk payments for asymptomatic PAD testing over the next 3 years.
---
Ownership Overview
18.33% Insiders
14.32% Mutual Funds
20.59% Other Institutional Investors
37.80% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SMLR FAQ
What was Semler Scientific’s price range in the past 12 months?
Semler Scientific lowest stock price was $20.88 and its highest was $81.56 in the past 12 months.
What is Semler Scientific’s market cap?
Semler Scientific’s market cap is $354.30M.
When is Semler Scientific’s upcoming earnings report date?
Semler Scientific’s upcoming earnings report date is May 13, 2025 which is in 44 days.
How were Semler Scientific’s earnings last quarter?
Semler Scientific released its earnings results on Feb 18, 2025. The company reported $3.41 earnings per share for the quarter, beating the consensus estimate of $0.26 by $3.15.
Is Semler Scientific overvalued?
According to Wall Street analysts Semler Scientific’s price is currently Undervalued.
Does Semler Scientific pay dividends?
Semler Scientific does not currently pay dividends.
What is Semler Scientific’s EPS estimate?
Semler Scientific’s EPS estimate is 0.26.
How many shares outstanding does Semler Scientific have?
Semler Scientific has 9,596,486 shares outstanding.
What happened to Semler Scientific’s price movement after its last earnings report?
Semler Scientific reported an EPS of $3.41 in its last earnings report, beating expectations of $0.26. Following the earnings report the stock price went up 2.957%.
Which hedge fund is a major shareholder of Semler Scientific?
Currently, no hedge funds are holding shares in SMLR
---
Semler Scientific Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$71.00 (92.62% Upside)
$71.00 (92.62% Upside)
Blogger Sentiment
Bullish
SMLR Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 163.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 7.2%
Last 30 Days ▼ 7.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
29.31%
12-Months-Change
Fundamentals
Return on Equity
27.04%
Trailing 12-Months
Asset Growth
211.18%
Trailing 12-Months
Company Description
Semler Scientific
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
---
SMLR Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant achievements, particularly in the successful adoption and execution of a Bitcoin treasury strategy, which has positively impacted market capitalization and resulted in substantial accretive purchases. However, challenges remain with declining revenues and a heavy dependence on a few major customers, indicating areas of concern.Read More>---
SMLR Stock 12 Month Forecast
Average Price Target
$71.00
▲(92.62% Upside)
Technical Analysis
Best Analysts Covering SMLR
1 Year
1 Year Success Rate
12/16 ratings generated profit
1 Year Average Return
+10.19%
reiterated a buy rating 2 months ago
Copying Brooks O'Neil's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +10.19% per trade.
---